UnitedHealth Group (NYSE:UNH) Stock Price Target Raised at Mizuho

UnitedHealth Group (NYSE:UNH) had its price target hoisted by Mizuho from $493.00 to $500.00 in a research note issued to investors on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the healthcare conglomerate’s stock. Mizuho’s target price points to a potential upside of 19.92% from the company’s current price.

UNH has been the subject of a number of other research reports. Evercore lifted their target price on UnitedHealth Group from $400.00 to $480.00 and gave the stock an “outperform” rating in a report on Tuesday, July 7th. JPMorgan Chase & Co. upped their price target on shares of UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a research note on Friday, October 16th. HC Wainwright set a $500.00 price objective on shares of UnitedHealth Group in a research note on Friday, October 16th. Robert W. Baird cut their price target on shares of UnitedHealth Group from $453.00 to $427.00 and set a “neutral” rating on the stock in a report on Wednesday, October 14th. Finally, Stephens set a $500.00 target price on UnitedHealth Group in a research note on Friday, October 16th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $463.80.

UnitedHealth Group Stock Down 0.6%

UnitedHealth Group stock opened at $416.95 on Thursday. The stock has a market cap of $374.25 billion, a P/E ratio of 23.81, a P/E/G ratio of 1.51 and a beta of 0.60. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66. UnitedHealth Group has a twelve month low of $255.96 and a twelve month high of $461.62. The company’s 50-day moving average price is $387.63 and its two-hundred day moving average price is $388.48.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. During the same quarter in the previous year, the company posted $2.59 earnings per share. The business’s revenue was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts expect that UnitedHealth Group will post 20.64 EPS for the current year.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 0.19% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On UnitedHealth Group

Hedge funds have recently made changes to their positions in the stock. Corient Private Wealth LP purchased a new position in shares of UnitedHealth Group during the second quarter worth $245,516,000. Legal & General Group Plc acquired a new position in UnitedHealth Group during the 2nd quarter worth $2,444,928,000. Jupiter Topco LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth about $2,019,844,000. BlackRock Inc. raised its position in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. Finally, Canada Pension Plan Investment Board acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $971,757,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.